Engineered human hepatocyte organoids enable CRISPR-based target discovery and drug screening for steatosis.
Hendriks D, Brouwers JF, Hamer K, Geurts MH, Luciana L, Massalini S, Lopez-Iglesias C, Peters PJ, Rodriguez-Colman MJ, Chuva de Sousa Lopes S, Artegiani B, Clevers H
Nat Biotechnol. 2023 Feb 23. doi: 10.1038/s41587-023-01680-4.
(Link opens in a new window)
PubMed
(Link opens in a new window)
Article
Plasmids from Article
No plasmids are currently publicly available from Addgene for this article.